Bupropion hydrochloride
- Product NDC
- 63304-723
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Bupropion hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Application
- ANDA200216
- Marketing category
- ANDA
- Substance
- BUPROPION HYDROCHLORIDE
- Current FDA listing
- Yes
Packages
| Package NDC | Description | Marketing start | Marketing end | Sample | Status |
|---|
| 63304-723-05 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-723-05) | 20201209 | | No | Historical |
| 63304-723-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-723-30) | 20201209 | | No | Historical |
| 63304-723-90 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-723-90) | 20201209 | | No | Historical |
Related DailyMed Labels
| Set ID | Title | Manufacturer | Effective date | Type | Version |
|---|
| 195b9970-0bc6-4f48-9450-a91292ad4618 | These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE EXTENDED-RELEASE TABLETS (XL). BUPROPION HYDROCHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1985 | Sun Pharmaceutical Industries, Inc. | Sun Pharmaceutical Industries Limited | 2025-12-15 | HUMAN PRESCRIPTION DRUG LABEL | 11 |